Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Vandana Singh

Vor Biopharma Secures $100 Million Offering After Reporting Efficacy In Kidney Disease Trial

Stuttgart,,Germany,-,10-11-2025:,Smartphone,With,Logo,Of,Us,Biotechnology

Vor Biopharma Inc. (NASDAQ:VOR) on Tuesday priced an underwritten public offering of 10 million shares at $10.00 per share.

The gross proceeds from the offering are expected to be $100 million.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.